BIOLARGO, INC. (55)

Browse by Contract Category

Contracts

Purchase Agreement, dated as of December 13, 2022, by and between BioLargo, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on December 19, 2022)
Form of Indemnity Agreement (Filed With SEC on November 3, 2022)
Amendment dated June 30, 2020 to Consulting Agreement dated December 30, 2015 between Clyra Medical and Beach House Consulting LLC (Filed With SEC on July 7, 2020)
Amendment dated June 30, 2020 to License Agreement with Clyra Medical Technologies, Inc (Filed With SEC on July 7, 2020)
Registration Rights Agreement, dated as of December 13, 2022, by and between BioLargo, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on December 19, 2022)
Form of Board Member Agreement (Filed With SEC on November 3, 2022)
Engagement Extension Agreement dated as of March 22, 2022 between BioLargo, Inc. and Charles K. Dargan, II (Filed With SEC on March 24, 2022)
Agreement dated March 3, 2022, by and between Clyra Medical Technologies, Inc., and BioLargo, Inc (Filed With SEC on March 8, 2022)
Agreement dated March 1, 2022, by and between Scion Solutions, LLC, Clyra Medical Technologies, Inc., and BioLargo, Inc (Filed With SEC on March 8, 2022)
Third Amendment dated August 10, 2020 to Promissory Note issued to Vernal Bay Investments, LLC on September 19, 2018 (Filed With SEC on May 19, 2021)
Amended and restated note issued to Chappy Bean on August 12, 2019 (Filed With SEC on May 19, 2021)
Second Amendment dated August 12, 2019, to Promissory Note issued to Chappy Bean, LLC dated September 19, 2018 (Filed With SEC on May 19, 2021)
Third Amendment dated August 10, 2020, to Promissory Note issued to Chappy Bean, LLC dated September 19, 2018 (Filed With SEC on May 19, 2021)
Final Payoff Agreement dated May 18, 2021 to Promissory Note issued to Chappy Bean, LLC dated September 19, 2018 (Filed With SEC on May 19, 2021)
Final Payoff Agreement dated May 17, 2021 to Promissory Note issued to Vernal Bay Investments, LLC on September 19, 2018 (Filed With SEC on May 19, 2021)
Warrant issued to $50,000 Convertible Noteholder on March 1, 2020 (Filed With SEC on March 30, 2021)
Amendment to $50,000 Convertible Note dated March 8, 2018 (Filed With SEC on March 30, 2021)
Engagement Extension Agreement dated as of March 18, 2021 between BioLargo, Inc. and Charles K. Dargan, II (Filed With SEC on March 19, 2021)
Warrant issued in 2020 Unit Offering (Filed With SEC on August 14, 2020)
Revolving Line of Credit Note issued by Clyra Medical to Vernal Bay on June 30, 2020 (Filed With SEC on July 7, 2020)
Revolving Line of Credit Agreement dated June 30, 2020, between Clyra Medical and Vernal Bay (Filed With SEC on July 7, 2020)
Security Agreement dated June 30, 2020, between Clyra Medical and Vernal Bay (Filed With SEC on July 7, 2020)
Purchase Agreement, dated as of March 30, 2020 by and between BioLargo, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on March 31, 2020)
Registration Rights Agreement, dated as of March 30, 2020, by and between BioLargo, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on March 31, 2020)
Engagement Extension Agreement dated as of February 23, 2020 between BioLargo, Inc. and Charles K. Dargan, II (Filed With SEC on February 27, 2020)
Warrant issued March 2018, expiring March 2023 (Filed With SEC on September 17, 2019)
Form of warrant issued January 2019 to Lincoln Park, expiring January 2024 (Filed With SEC on September 17, 2019)
Form of warrant issued January 2019 to Lincoln Park, expiring January 2024 (Filed With SEC on August 29, 2019)
Warrant issued March 2018, expiring March 2023 (Filed With SEC on August 29, 2019)
Warrant issued to Vernal August 12, 2019 (Filed With SEC on August 14, 2019)
Amended and restated note issued to Vernal August 12, 2019 (Filed With SEC on August 14, 2019)
Amendment dated August 12, 2019 to Promissory Note issued to Vernal Bay Investments, LLC on September 19, 2018 (Filed With SEC on August 14, 2019)
Warrant to purchase 1.2 million shares issued August 9, 2019 to $600,000 note holder (Filed With SEC on August 14, 2019)
$600,000 Promissory note dated August 9, 2019 (Filed With SEC on August 14, 2019)
Stock purchase warrant issued to OID twelve-month investors (Filed With SEC on August 2, 2019)
OID twelve-month promissory note (Filed With SEC on August 2, 2019)
Lock-Up Agreement dated May 28, 2019 (Filed With SEC on June 24, 2019)
Provenzano Employment Agreement dated May 28, 2019 (Filed With SEC on June 24, 2019)
Securities Purchase Agreement by and between BioLargo, Inc., and EMA Financial, LP dated June 4, 2019 (Filed With SEC on June 7, 2019)
Amendment #1 to the Convertible Note issued on June 4, 2019 to EMA Capital, LP (Filed With SEC on June 7, 2019)
10% Convertible Promissory Note issued to EMA Financial, LP dated June 4, 2019 (Filed With SEC on June 7, 2019)
Convertible Promissory Note issued to Crossover Capital dated May 10, 2019 (Filed With SEC on May 15, 2019)
Securities Purchase Agreement by and between BioLargo, Inc., and Crossover Capital dated May 10, 2019 (Filed With SEC on May 15, 2019)
10% Convertible Promissory Note issued to Bellridge Capital, LP dated April 18, 2019 (Filed With SEC on April 23, 2019)
Securities Purchase Agreement by and between BioLargo, Inc., and Bellridge Capital, LP dated April 18, 2019 (Filed With SEC on April 23, 2019)
Amendment dated March 5, 2019 to Convertible Promissory Note issued to Tangiers Global, LLC dated January 31, 2019 (Filed With SEC on March 8, 2019)
Amendment dated March 5, 2019 to Promissory Note issued to Chappy Bean, LLC on September 19, 2018 (Filed With SEC on March 8, 2019)
Amendment dated March 5, 2019 to Promissory Note issued to Vernal Bay Investments, LLC on September 19, 2018 (Filed With SEC on March 8, 2019)
Stock Purchase Warrant issued to Lincoln Park Capital on January 31, 2019 (Filed With SEC on February 11, 2019)
Convertible Promissory Note issued to Tangiers Global, LLC dated January 31, 2019 (Filed With SEC on February 11, 2019)
Engagement Extension Agreement dated as of January 16, 2019 between BioLargo, Inc. and Charles K. Dargan, II (Filed With SEC on January 18, 2019)
Convertible Promissory Note issued to Vista Capital Investments LLC dated January 7, 2019 (Filed With SEC on January 11, 2019)
January 2019 Amendment to Promissory Note dated December 14, 2017, by and between BioLargo, Inc. and Vista Capital Investments, LLC (Filed With SEC on January 11, 2019)
Engagement Extension Agreement dated as of December 31, 2017 between BioLargo, Inc. and Charles K. Dargan, II (Filed With SEC on January 3, 2018)
Option to purchase common stock issued to Charles K. Dargan dated December 31, 2017 (Filed With SEC on January 3, 2018)